Analgesics in
Country Report
Executive Summary
Oct 2019PROSPECTS
Ageing population set to contribute strongly to forecast growth
Analgesics saw strong current value growth in 2019, and is expected to continue to see a good performance in the forecast period. Demographic trends have a significant impact on retail sales of analgesics in Ukraine.
Advertising ensures demand for brands, despite the lower prices of generics
Advertising campaigns, especially those run on national television channels in support of a number of international brands, such as Nurofen and Deep Relief, play an important role in shaping consumers’ interest in analgesics. Whilst there is a strong tradition of taking generics such as Analgin, Paracetamol and Citramon for combating pain, multinational companies attract consumers to their more expensive brands through shaping a strong brand image.
Diversification of positioning to increase consumers’ interest
At the end of the review period, analgesics was one of the most established and mature categories within consumer health in Ukraine. Such products are popular amongst Ukrainians, who often aim to alleviate symptoms through painkillers alone.
COMPETITIVE LANDSCAPE
Analgesics sees strong competition between brands and generics
In 2019, analgesics was represented by a number of domestic and international companies, the biggest of which were multinational player Reckitt Benckiser Household & Healthcare Ukraine and the local player Darnitsa. Overall leadership in analgesics is ensured by various factors, including: early market entry, with generics Citramon and Paracetamol well-known and popular for decades; pricing, with generics typically having the appeal of low prices; efficacy, with imported brands believed to be more effective; and promotional support, with multinational brands such as Nurofen attracting consumers through strong advertising.
New product development expected, hoping to boost slowing growth
New product development is an area of investment which can enhance a player’s position in analgesics, but at the end of the review period there were no noteworthy new launches. In the future the situation is likely to change, with investments in innovations including not only formulations, but also more convenient packaging and formats.
Strong growth for Spasmalgon thanks to efficacy and advertising
Spasmalgon from Teva Ukraine was the leading brand within the popular combination analgesics category in 2019, and saw a strong value increase in this year. It continued to see growth in both its sales and share within this category, as well as within overall analgesics, as it is perceived by consumers as an efficient combination product which is well-supported by advertising; television advertising in particular.
Your Recently Viewed Reports
Analgesics in Ukraine
Samples (FAQs about samples):
Delivery: Files are delivered directly into your account within a few minutes of purchase.
Overview
Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in Ukraine with research from Euromonitor's team of in-country analysts.
Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.
If you're in the Analgesics industry in Ukraine, our research will save you time and money while empowering you to make informed, profitable decisions.
The Analgesics in Ukraine market research report includes:
- Analysis of key supply-side and demand trends
- Detailed segmentation of international and local products
- Historic volumes and values, company and brand market shares
- Five year forecasts of market trends and market growth
- Robust and transparent market research methodology, conducted in-country
Our market research reports answer questions such as:
- What is the market size of Analgesics in Ukraine?
- What are the major brands in Ukraine?
- Are combination products with acetaminophen still popular?
Why buy this report?
- Gain competitive intelligence about market leaders
- Track key industry trends, opportunities and threats
- Inform your marketing, brand, strategy and market development, sales and supply functions
This industry report originates from Passport, our Consumer Health market research database.
Analgesics in Ukraine - Category analysis
HEADLINES
PROSPECTS
Ageing population set to contribute strongly to forecast growth
Advertising ensures demand for brands, despite the lower prices of generics
Diversification of positioning to increase consumers’ interest
COMPETITIVE LANDSCAPE
Analgesics sees strong competition between brands and generics
New product development expected, hoping to boost slowing growth
Strong growth for Spasmalgon thanks to efficacy and advertising
CATEGORY DATA
Table 1 Sales of Analgesics by Category: Value 2014-2019Table 2 Sales of Analgesics by Category: % Value Growth 2014-2019
Table 3 NBO Company Shares of Analgesics: % Value 2015-2019
Table 4 LBN Brand Shares of Analgesics: % Value 2016-2019
Table 5 Forecast Sales of Analgesics by Category: Value 2019-2024
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2019-2024
Consumer Health in Ukraine - Industry Overview
EXECUTIVE SUMMARY
Economic recovery plays a key role, with rising incomes boosting sales
Strong self-medication trend despite growing concerns
Consumer health is a battlefield for big players, both international and local
Chemists/pharmacies still dominates, but sees a constant share decline
Despite challenges, strong growth expected, boosted by preventative medication
MARKET INDICATORS
Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2014-2019Table 8 Life Expectancy at Birth 2014-2019
MARKET DATA
Table 9 Sales of Consumer Health by Category: Value 2014-2019Table 10 Sales of Consumer Health by Category: % Value Growth 2014-2019
Table 11 NBO Company Shares of Consumer Health: % Value 2015-2019
Table 12 LBN Brand Shares of Consumer Health: % Value 2016-2019
Table 13 Distribution of Consumer Health by Format: % Value 2014-2019
Table 14 Distribution of Consumer Health by Format and Category: % Value 2019
Table 15 Forecast Sales of Consumer Health by Category: Value 2019-2024
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2019-2024
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
Summary 1 OTC: Switches 2018-2019DEFINITIONS
SOURCES
Summary 2 Research SourcesRelated Reports
- Bayer in Consumer Health | Nov 2019
- Johnson & Johnson in Consumer Health | Nov 2019
- Consumer Health in Taiwan | Oct 2019
- Vitamins and Dietary Supplements in Latin America | Oct 2019
- Digestive Remedies in Western Europe | Oct 2019